Sign in

CIK 0001326190

  • Non-accelerated filer
  • Smaller reporting company

Altimmune, Inc.

Sign in to watch
Ticker
ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
202726770
Phone
+1 862-457-1450
Business address
350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
Former names
PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale Director sold 329,354 shares at $2.20 ($724,579)
  4. 4 Open-market sale Director sold 11,767 shares at $2.20 ($25,887)
  5. 4 Grant or award VP, CFO, Treasurer, Secretary acquired 25,000 shares (grant or award)
  6. 4 Grant or award President and CEO acquired 612,244 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award CFO acquired 25,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 25,000 shares at $1.65 ($41,213)
  16. 4 Grant or award COO acquired 25,000 shares (grant or award)
  17. 4 Open-market sale SVP, CFO & Secretary sold 29,600 shares at $2.10 ($62,160)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 20 of 34 · 675 filings